• About Stallergenes
  • Sciences & innovation
  • Healthcare professionals
  • Being allergic
  • Media
  • Careers
Media
  • Press release
    • 2008
    • 2007
    • 2006
    • Archives
  • In brief
  • Ask a question
  • Communication Department
  • Media
  • Press release
  • 2008
2008
Print Print

Select a category:

Finance
Products
R&D
Partnership
Group activities
Environment and allergies
Please enter a searchword.

27/08/08
Oralair® Grasses 300 IR : Highly positive clinical results in a pharmacodynamic study conducted in an allergen challenge chamber
Category: R&D

[more]

28/07/08
Phase III clinical trial for Staloral® 300 in China
Category: R&D

Stallergenes launches a phase III clinical trial for Staloral® 300 in China

[more]

10/06/08
Phase II/III clinical trial on a tablet for desensitisation to mites
Category: R&D

Stallergenes has started a phase II/III clinical trial on a tablet for desensitisation to mites

[more]
 
 
Retour à l'accueil
Investors Website
  • International
    • Belgique
    • Česko
    • Deutschland
    • España
    • France
    • Italia
    • Nederland
    • Polska
    • Portugal
    • Slovensko
Home
Contact
 
 
Sitemap | Legal | Credits
Last update: 06/09/2007 © 2007 - Stallergenes